France · 
Who invested in ENTEROME Bioscience?
ENTEROME Bioscience's investors include Seventure Partners, Lundbeckfond Ventures and Omnes.
20132014
$6.6MSeries A$14MSeries BFrance · Series B startup
Who invested in ENTEROME Bioscience
2 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$20Mraised across 2 rounds since 2012, from 2 sources
$6.6MSeries A$14MSeries B
- Latest round
- Series B, $14MMay 2014
- Step-upi
- 2.1×
- Investors
- 3
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Series A, $6.6M Mar 2012
- Biggest round
- $14M Series B · May 2014
- Between rounds
- 2.1 years from the last two
The rounds
- May 2014Series B$14M1 new2 returning
From a historical funding record
- Mar 2012
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about ENTEROME Bioscience
How much has ENTEROME Bioscience raised?
ENTEROME Bioscience has raised $20M across 2 rounds since 2012.
When did ENTEROME Bioscience last raise?
ENTEROME Bioscience's most recent round was a Series B of $14M in May 2014.
What was ENTEROME Bioscience's biggest round?
Its most recent round, $14M in May 2014, is also its largest on record.
Who backed ENTEROME Bioscience first?
ENTEROME Bioscience's first round on record, in Mar 2012, was backed by Seventure Partners and Lundbeckfond Ventures.
What stage is ENTEROME Bioscience at?
ENTEROME Bioscience's latest named round is a Series B, in May 2014.
Where is ENTEROME Bioscience based?
ENTEROME Bioscience is based in France.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.